AJANTPHARM

Shares of

rose 2.09% to Rs 2,824.90 in Tuesday's session, driven by bullish investor sentiment. The stock is among the top gainers on the Nifty Midcap 150 index. On the financial front, the consolidated revenue for Ajanta Pharma showed consistent growth. Quarterly revenue increased from Rs 1,144.92 Crore in June 2024 to Rs 1,302.65 Crore in June 2025. Net profit also rose from Rs 245.77 Crore to Rs 255.34 Crore during the same period. The EPS increased from Rs 19.54 to Rs 20.44. The annual consolidated revenue grew from Rs 4,208.71 Crore in 2024 to Rs 4,648.10 Crore in 2025. Annual net profit increased from Rs 816.17 Crore to Rs 920.39 Crore, and EPS grew from Rs 64.82 to Rs 73.56. Ajanta Pharma announced an interim dividend of Rs 28 per share on October 25, 2024, with an effective date of November 6, 2024. Additionally, a bonus issue was announced on May 10, 2022, with a bonus ratio of 1:2 and an ex-bonus date of June 22, 2022. The company's stock split history includes splits announced on January 28, 2015 (old FV of 5, new FV of 2, ex-split date of March 20, 2015) and April 26, 2012 (old FV of 10, new FV of 5, ex-split date of August 9, 2012).